Neurology Edition: Top Headlines for Week of September 19, 2022

In this edition, FDA votes to support approval of ALS therapy; partnership offers military veterans access to psychedelics; epidural steroid injections as alternate pain management options and more.

Read the full coverage here:

FDA advisory committee votes to support approval of ALS therapy

Partnership offers military veterans access to psychedelics at home, abroad

Epidural steroid injection an alternate pain management option

Ketamine may be effective in treating children with ADNP syndrome

FDA accepts new drug application for Rett syndrome treatment

References:

Christo PJ. Landscape of wonders: Injections, nerve blocks, pumps and neuromodulation. Presented at: PAINWeek; Las Vegas; Sept. 9-12, 2022.

Kolevzon A, et al. HGG Adv. 2022;doi:10.1016/j.xhgg.2022.100138.

Press Release

Press Release

Press Release